Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. 詳細を表示
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
12 | -0.75 | -16.2162162162 | 4.625 | 5.705 | 3.15 | 889830 | 3.95341625 | CS |
26 | -1.8075 | -31.808183018 | 5.6825 | 9.395 | 3.15 | 1199411 | 5.16324116 | CS |
52 | -10.375 | -72.8070175439 | 14.25 | 23.5 | 3.15 | 802211 | 6.26251738 | CS |
156 | -121.625 | -96.9123505976 | 125.5 | 227.7725 | 3.15 | 702693 | 17.18099824 | CS |
260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 573647 | 29.32782664 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約